APIXABAN-FORMULIERUNGEN

European patent · EP3017811 · Deleted

Register entry

Publication number
EP3017811
Application number
EP15190823
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Feb 24, 2011
Published
May 11, 2016
Granted
Dec 5, 2018
Deleted
Apr 24, 2024
Reason
Revoked in opposition
IPC classes
A61K 9/20 (2006.01)
A61K 31/4545 (2006.01)
A61P 7/02 (2006.01)
Priority
US 308056 P 25.02.2010
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 26, 2024

    Publication

    Published in Swissreg on 26.04.2024

  2. Apr 24, 2024

    Change

    Published in Swissreg on 24.04.2024

  3. Mar 27, 2024

    Change

    Published in Swissreg on 27.03.2024

  4. Mar 1, 2024

    Change

    Published in Swissreg on 01.03.2024

  5. Dec 27, 2023

    Change

    Published in Swissreg on 27.12.2023

  6. Mar 6, 2023

    Change

    Published in Swissreg on 06.03.2023

  7. Jan 9, 2023

    Address changed

    Representative
    ServoPatent GmbH, Wannerstrasse 9/1, 8045 Zürich → Servopatent GmbH, Bühlstrasse 1, 8125 Zollikerberg

    Published in Swissreg on 09.01.2023

  8. Feb 16, 2022

    Change

    Published in Swissreg on 16.02.2022

7 earlier entries
  1. Oct 27, 2021

    Change

    Published in Swissreg on 27.10.2021

  2. Sep 23, 2021

    Change

    Published in Swissreg on 23.09.2021

  3. Sep 23, 2021

    Change

    Published in Swissreg on 23.09.2021

  4. Jun 4, 2020

    Address changed

    Representative
    Servopatent GmbH, Resirain 1, 8125 Zollikerberg → ServoPatent GmbH, Wannerstrasse 9/1, 8045 Zürich

    Published in Swissreg on 04.06.2020

  5. Mar 14, 2019

    Agent entered

    Representative
    Servopatent GmbH, Resirain 1, 8125 Zollikerberg

    Published in Swissreg on 14.03.2019

  6. Mar 6, 2019

    Owner

    Owner
    Pfizer Inc., 235 East 42nd Street, New York, NY 10017, USA, Bristol-Myers Squibb Holdings Ireland, Hinterbergstrasse 16, 6312 Steinhausen → Pfizer Inc., 235 East 42nd Street, New York, NY 10017, USA, Bristol-Myers Squibb Holdings Ireland, Unlimited Company, Hinterbergstrasse 16, 6312 Steinhausen

    Published in Swissreg on 06.03.2019

  7. Dec 5, 2018

    Granted

    Published in Swissreg on 05.12.2018

Parties

Inventor

FROST, Charles

Princton, NJ New Jersey 08543, US

PATEL, Jatin

Princton, NJ New Jersey 08543, US

JIA, Jingpin

Princton, NJ New Jersey 08543, US

VEMA-VARAPU, Chandra

Princton, NJ New Jersey 08543, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.